Filing metadata

Accession number
0001209191-16-110683
Form type
Form 3
Filer
Eiger BioPharmaceuticals, Inc.
CIK
CIK 1305253
Filed
Mar 25, 2016
Reporting period
Mar 22, 2016
Description
Initial ownership

Explore SEC Filings Hub